New study aims to cut unnecessary antibiotics in newborns
NCT ID NCT06845332
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will roll out three proven antibiotic stewardship strategies in Dutch hospitals to see if they reduce unnecessary antibiotic use in newborns with suspected early-onset sepsis. Researchers will compare data from before and after the strategies are put in place, involving up to 55,000 babies born at 34 weeks or later. The goal is to make care more consistent and safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antibiotic stewardship strategies (EOS calculator, procalcitonin-guided therapy, IV-to-oral switch)
What this could lead to
If successful, this could help standardize safe antibiotic use in newborns, reducing unnecessary treatment and hospital stays.
What could go wrong
This is an implementation study, not a test of new drugs. Results may vary across hospitals, and the strategies may not reduce antibiotic use as expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-ONSET NEONATAL SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Admiraal de Ruyter Ziekenhuis
RECRUITINGGoes, Netherlands
-
Albert Schweitzer Ziekenhuis
RECRUITINGDordrecht, Netherlands
-
Antonius Ziekenhuis Sneek
RECRUITINGSneek, Netherlands
-
Canisius Wilhelmina Ziekenhuis
RECRUITINGNijmegen, Netherlands
-
Catharina Ziekenhuis
RECRUITINGEindhoven, Netherlands
-
Gelre Ziekenhuis
RECRUITINGApeldoorn, Netherlands
-
Medisch Centrum Leeuwarden
RECRUITINGLeeuwarden, Netherlands
-
Noordwest Ziekenhuisgroep
RECRUITINGAlkmaar, Netherlands
-
Tjongerschans Ziekenhuis
RECRUITINGHeerenveen, Netherlands
-
Treant Ziekenhuis
RECRUITINGEmmen, Netherlands
-
Zuyderland Medisch
RECRUITINGHeerlen, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could preterm babies safely get fewer antibiotics?
- New study aims to perfect antibiotic dosing for newborns
- Could shorter antibiotics work just as well for newborns?
- NICU antibiotic study questions routine use for tiniest babies
- Blood test could spare thousands of preemies from unnecessary antibiotics